Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Jommi

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Global & Regional Health Technology Assessment|May 8, 2023
Eugenio Di Brino, Claudio Jommi
Health Policy (Amsterdam, Netherlands)|February 27, 2018
Variations in non-prescription drug consumption and expenditure: Determinants and policy implicationsMonica Otto, Patrizio Armeni, Claudio Jommi
Global & Regional Health Technology Assessment|October 9, 2023
Claudio Jommi, Michela Meregaglia, Carmine Pinto
BMJ Open|January 14, 2021
Key drivers of innovativeness appraisal for medicines: the Italian experience after the adoption of the new ranking systemCarlotta Galeone, Paolo Bruzzi, Claudio Jommi
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 28, 2012
The impact of generic reference pricing in Italy, a decade onSimone Ghislandi, Patrizio Armeni, Claudio Jommi
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 29, 2015
The simultaneous effects of pharmaceutical policies from payers' and patients' perspectives: Italy as a case studyPatrizio Armeni, Claudio Jommi, Monica Otto
Clinical Drug Investigation|March 9, 2021
Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side EffectsCarla Rognoni, Arianna Bertolani, Claudio Jommi
Health Policy (Amsterdam, Netherlands)|April 4, 2008
Pharmaceutical companies and Italian Regional Governments: managing relationships in an increasing institutional complexityAmelia Compagni, Laura Cavalli, Claudio Jommi
Frontiers in Pharmacology|November 3, 2018
The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in ItalyMonica Hildegard Otto, Carla Pillarella, Claudio Jommi
Frontiers in Pharmacology|March 21, 2019
Corrigendum: The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in ItalyMonica Hildegard Otto, Carla Pillarella, Claudio Jommi
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Global & Regional Health Technology Assessment|May 8, 2023
Eugenio Di Brino, Claudio Jommi
Health Policy (Amsterdam, Netherlands)|February 27, 2018
Variations in non-prescription drug consumption and expenditure: Determinants and policy implicationsMonica Otto, Patrizio Armeni, Claudio Jommi
Global & Regional Health Technology Assessment|October 9, 2023
Claudio Jommi, Michela Meregaglia, Carmine Pinto
BMJ Open|January 14, 2021
Key drivers of innovativeness appraisal for medicines: the Italian experience after the adoption of the new ranking systemCarlotta Galeone, Paolo Bruzzi, Claudio Jommi
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|November 28, 2012
The impact of generic reference pricing in Italy, a decade onSimone Ghislandi, Patrizio Armeni, Claudio Jommi
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 29, 2015
The simultaneous effects of pharmaceutical policies from payers' and patients' perspectives: Italy as a case studyPatrizio Armeni, Claudio Jommi, Monica Otto
Clinical Drug Investigation|March 9, 2021
Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side EffectsCarla Rognoni, Arianna Bertolani, Claudio Jommi
Health Policy (Amsterdam, Netherlands)|April 4, 2008
Pharmaceutical companies and Italian Regional Governments: managing relationships in an increasing institutional complexityAmelia Compagni, Laura Cavalli, Claudio Jommi
Frontiers in Pharmacology|November 3, 2018
The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in ItalyMonica Hildegard Otto, Carla Pillarella, Claudio Jommi
Frontiers in Pharmacology|March 21, 2019
Corrigendum: The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in ItalyMonica Hildegard Otto, Carla Pillarella, Claudio Jommi
Pageof 9